Hemostasis, fibrinolysis, and natural anticoagulation in transplant vascular sclerosis.
Faulk
W P
WP
Center for Reproduction and Transplantation Immunology, Methodist Hospital, Indianapolis, Ind. 46202, USA.
Labarrere
C A
CA
Nelson
D R
DR
Pitts
D
D
D000328:Adult; D000925:Anticoagulants / Q000097:blood*; D001706:Biopsy; D003324:Coronary Artery Disease / Q000097:blood* / Q000473:pathology / Q000517:prevention & control; D003331:Coronary Vessels / Q000473:pathology / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000473:pathology / Q000503:physiopathology; D005260:Female; D005337:Fibrin / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects / Q000502:physiology*; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000473:pathology / Q000502:physiology*; D006487:Hemostasis / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008856:Microscopy, Fluorescence; D011183:Postoperative Complications / Q000097:blood* / Q000473:pathology / Q000517:prevention & control; D016019:Survival Analysis; D010959:Tissue Plasminogen Activator / Q000378:metabolism
D000925:Anticoagulants; D007166:Immunosuppressive Agents; D005337:Fibrin; D010959:Tissue Plasminogen Activator